Pfizer Australia Pty Ltd—Dostinex, Cabaser and Methoblastin

Identifying features

Dostinex (cabergoline), Cabaser (cabergoline) & Methoblastin (methotrexate) - All Batches

Dostinex (cabergoline) 0.5 mg tablet, bottles of 2 and 8
AUST R number: 52158

Cabaser (cabergoline) 1 mg tablet, bottles of 30
AUST R number: 57360

Cabaser (cabergoline) 2 mg tablet, bottles of 30
AUST R number: 57367

METHOBLASTIN (methotrexate) 2.5 mg tablets, bottles of 30
AUST R number: 15418

METHOBLASTIN (methotrexate) 10 mg tablets, bottles of 15 & 50
AUST R number: 15417

What are the defects?

The products have been supplied in containers without child-resistant closures. Please note that there is no concern regarding the quality or safety of this medicine other than the absence of child resistant packaging.

What are the hazards?

If children gain access to the products there is the potential for inadvertent poisoning.

What should consumers do?

Consumers are asked to return any affected product to their Pharmacy to have either the cap or the container replaced with new child resistant closures.

Pfizer Australia Pty Ltd
Traders who sold this product

Various Pharmacies nationwide

Where the product was sold

Responsible regulator

Therapeutic Goods Administration is the responsible regulator for this recall.

Product category